Lv1
20 积分 2022-10-18 加入
Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy
13天前
已完结
Immunoglobulin Light Chain Amyloidosis: 2026 Update on Diagnosis, Prognosis, and Treatment
14天前
已完结
Diagnostic challenges in light chain (AL) amyloidosis for high-risk patients
14天前
已完结
Iberdomide plus daratumumab and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (EXCALIBER-RRMM): an open-label, randomised, controlled, phase 3 trial
1个月前
已完结
Iberdomide plus daratumumab and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (EXCALIBER-RRMM): an open-label, randomised, controlled, phase 3 trial
1个月前
已完结
B-Cell Lymphomas, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology
1个月前
已完结
End of transplantation's reign in mantle cell lymphoma
1个月前
已完结
Mantle Cell Lymphoma in Geriatric Patients: Biologic Risk Stratification, Fitness-Adapted Strategies, and Unmet Needs
1个月前
已完结
Mantle Cell Lymphoma in Geriatric Patients: Biologic Risk Stratification, Fitness‐Adapted Strategies, and Unmet Needs
1个月前
已关闭
Investigating the role of costimulatory domains in enhancing CAR-T cell persistence in TNBC
2个月前
已完结